Learn More
INTRODUCTION Optimal preoperative treatment of stage IIB (Pancoast)/III non-small cell lung cancer (NSCLC) remains undetermined and a subject of controversy. The goal of our study is to confirm(More)
Introduction Le nivolumab (N) est un traitement de reference du cancer bronchique non a petites cellules (CBNPC) des la 2 e ligne. En 2015, un programme d’autorisation temporaire d’utilisation du N a(More)
BackgroundWith the recent introduction of novel treatment options, real-world data from patients with metastatic castration-resistant prostate cancer (mCRPC) are required to better understand the(More)